Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. (2019)

First Author: Chen YL
Attributed to:  Proximity to Discovery - University of Oxford funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aax2945

PubMed Identifier: 31645451

Publication URI: http://europepmc.org/abstract/MED/31645451

Type: Journal Article/Review

Volume: 11

Parent Publication: Science translational medicine

Issue: 515

ISSN: 1946-6234